Real-time enrollment status for this netherton syndrome clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 11:40 AM UTC
| NCT Number | NCT06539507 |
| Recruiting Status | Recruiting |
| Condition | Netherton Syndrome |
| Phase | PHASE1 |
| Target Enrollment | 78 participants |
| Active Locations | 5 sites in the US |
| Sponsor | BioCryst Pharmaceuticals |
| Last Updated on CT.gov | August 27, 2026 (Aug 27, 2026) |
As of October 16, 2026: Clinical trial NCT06539507 is currently recruiting participants. This phase1 study for netherton syndrome is actively seeking new participants at 5 locations across the United States. The study is sponsored by BioCryst Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06539507 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06539507 was last updated Aug 27, 2026 (August 27, 2026). HelloStudys verifies this status automatically.